Abstract

Congenital heart disease, the most frequent malformation at birth, is usually not fatal but leads to multiple hospitalisations and outpatient visits, with negative impact on the quality of life and psychological profile not only of children but also of their families. In this paper, we describe the entire architecture of a system for remotely monitoring paediatric/neonatal patients with congenital heart disease, with the final aim of improving quality of life of the whole family and reducing hospital admissions. The interesting vital parameters for the disease are ECG, heart rate, oxygen saturation, body temperature and body weight. They are collected at home using some biomedical sensors specifically selected and calibrated for the paediatric field. These data are then sent to the smart hub, which proceeds with the synchronisation to the remote e-Health care center. Here, the doctors can log and evaluate the patient’s parameters. Preliminary results underline the sensor suitability for children and infants and good usability and data management of the smart-hub technology (E@syCare). In the clinical trial, some patients from the U.O.C. Paediatric and Adult Congenital Cardiology- Monasterio Foundation are enrolled. They receive a home monitoring kit according to the group they belong to. The trial aims to evaluate the effects of the system on quality of life. Psychological data are collected through questionnaires filled in by parents/caregivers in self-administration via the gateway at the beginning and at the end of the study. Results highlight an overall improvement in well-being and sleep quality, with a consequent reduction in anxious and stressful situations during daily life thanks to telemonitoring. At the same time, users reported a good level of usability, ease of data transmission and management of the devices.

Highlights

  • quality of life (QoL) has been evaluated through a battery of psychometric tests, provided at the beginning and the end of the trial via the smart-hub

  • The level of interest in the use of the devices even at the end of the experiment (Q4 of Figure 9) was good, with low and very low values. This was probably due to the fact that the use of telemedicine does not completely exclude the phase of knowledge required by Congenital heart disease (CHD) for few months patients

  • Congenital heart disease is a malformation of the heart or great vessels, which affects about 1% of newborns

Read more

Summary

Introduction

In 40% of cases, there is the need for psychotherapy [8] In this scenario, telemedicine platforms could allow the remote monitoring of paediatric and neonatal patients, giving the parents a greater sense of security. Telemedicine platforms could allow the remote monitoring of paediatric and neonatal patients, giving the parents a greater sense of security The use of this kind of systems is growing, thanks to innovations in the Information & Communication Technology (ICT) sector. With the AIR CARDIO project, we propose a home telemonitoring system for paediatric/neonatal patients with CHD in both pre- and post-operative phases This system includes the remote monitoring of both the biomedical data and psychological/emotional state of patients.

Related Works
System Architecture
Biomedical Sensor Module
Smart-Hub Module
Clinical Trial
Clinical Evaluation
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call